Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting SystemConcetta Rafaniello, Carmen Ferrajolo, Maria Giuseppa Sullo, et al.Frontiers in Psychiatry|December 21, 2020
We Really Need Clear Guidelines and Recommendations for Safer and Proper Use of Aripiprazole and Risperidone in a Pediatric Population: Real-World Analysis of EudraVigilance DatabaseConcetta Rafaniello, Maria Giuseppa Sullo, Carla Carnovale, et al.Pharmacological Research|January 8, 2016
Risk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: Results of a pharmacovigilance reporting systemConcetta Rafaniello, Carmen Ferrajolo, Maria Giuseppa Sullo, et al.Frontiers in Cardiovascular Medicine|October 10, 2022
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summaryAnnamaria Mascolo, Raffaella Di Napoli, Nunzia Balzano, et al.Expert Opinion on Drug Safety|August 30, 2014
The importance of monitoring adverse drug reactions in pediatric patients: the results of a national surveillance program in ItalyCarla Carnovale, Tatiana Brusadelli, GianVincenzo Zuccotti, et al.Diabetes Research and Clinical Practice|February 18, 2015
Trends in the prescription of antidiabetic medications from 2009 to 2012 in a general practice of Southern Italy: a population-based studyConcetta Rafaniello, Vincenzo Arcoraci, Carmen Ferrajolo, et al.Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 VaccinesConcetta Rafaniello, Mario Gaio, Alessia Zinzi, et al.Plos One|July 30, 2014
Pattern of statin use in southern italian primary care: can prescription databases be used for monitoring long-term adherence to the treatment?Carmen Ferrajolo, Vincenzo Arcoraci, Maria Giuseppa Sullo, et al.Journal of Clinical Medicine|December 9, 2023
Two Years of Active Pharmacovigilance Surveillance and Therapeutic Reconciliation in Frail Populations: The MEAP 3.0 StudyAnna Bombelli, Greta Guarnieri, Niccolò Lombardi, et al.Expert Opinion on Drug Safety|November 24, 2016
Second generation antipsychotics in 'real-life' paediatric patients. Adverse drug reactions and clinical outcomes of drug switchConcetta Rafaniello, Marco Pozzi, Simone Pisano, et al.Pageof 3